Freeman Kevin D
Galectin Therapeutics Inc. · Director
Freeman Kevin D is listed in public filings as director. This Freeman Kevin D insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Galectin Therapeutics Inc. (GALT). Investors use Freeman Kevin D's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $182k60k shares | Grant / ExerciseJan 16, 2026 | $182.4K60k shares | $3.04 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $196k55.3k shares | BuyDec 23, 2025 | $19.5K5.5k shares | $3.55 | -- | |
| $144k49.8k shares | BuyJul 17, 2025 | $14.5K5k shares | $2.90 | -- | |
| $74k60k shares | Grant / ExerciseJan 23, 2025 | $73.8K60k shares | $1.23 | -- | |
| $36k44.8k shares | BuyDec 24, 2024 | $8.1K10k shares | $0.8134 | -- | |
| $92k34.8k shares | BuyOct 17, 2024 | $3.4K1.3k shares | $2.64 | -- | |
| $90k33.5k shares | BuyOct 16, 2024 | $13.5K5k shares | $2.70 | -- | |
| $68k28.5k shares | BuyJun 20, 2024 | $6.0K2.5k shares | $2.38 | -- |